CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 35 enrolled
Drug / intervention
allopurinol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01988402
NCT01988402Phase 4Completed

Does Allopurinol Prolong a Treated, Acute Gout Flare?

59th Medical Wing·interventional·Posted Nov 20, 2013·Updated Feb 14, 2018

In Brief

A Phase 4 clinical trial evaluating allopurinol and Placebo (sugar pill) for Gout. Completed, enrolled 35 participants across 1 site.

Detailed Summary

This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGout
CountriesUnited States

Timeline

Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 20, 2013
Enrollment StartDec 1, 2007
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 12.6 years ago

Interventions

allopurinoldrug

Placebo (sugar pill)drug